EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

CHI3L1 in Multiple Sclerosis—From Bench to Clinic

Izabela Jatczak-Pawlik iD, Anna Jurewicz, Małgorzata Domowicz iD, Alicja Ewiak-Paszyńska iD, Mariusz Stasiołek iD

Cells · 2024

DOI: 10.3390/cells13242086 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cells, 2024. Verfasst von Izabela Jatczak-Pawlik und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Medical University of Lodz, Kosciuszki Street 4, 90-419 Lodz, Poland. Hauptthemen laut MEDLINE: Multiple Sclerosis, Chitinase-3-Like Protein 1, Biomarkers. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 149 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Multiple sclerosis (MS) is a chronic demyelinating disease of the central nervous system (CNS) with a complex and not fully understood etiopathological background involving inflammatory and neurodegenerative processes. CHI3L1 has been implicated in pathological conditions such as inflammation, injury, and neurodegeneration, and is likely to play a role in the physiological development of the CNS. CHI3L1 is primarily produced by CNS macrophages, microglia, and activated astrocytes. The CHI3L1 expression pattern in MS lesions might support the important role of astrocytes in modulating inflammatory processes in this disease. The potential applications of CHI3L1 as a biomarker in MS are multifactorial. The measurement of CHI3L1 in body fluids might find its role in the early diagnosis of MS. In further stages, the monitoring of CHI3L1 levels might provide information on disease severity and progression, enabling a better adjustment of therapeutic strategies. Importantly, CHI3L1 might potentially serve as a marker of ongoing glial activation, reflecting the dynamic response of the CNS cells to the inflammatory processes in MS. Although preliminary findings have been promising, further research is needed to validate the utility of CHI3L1 measurements in the diagnosis and prediction of the progression of MS. Additionally, comparisons with other biomarkers might be useful in clinical practice.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Multiple SclerosisChitinase-3-Like Protein 1BiomarkersHumansAnimalsInflammation

Stichwörter der Autor:innen

biomarkerscerebrospinal fluidchitinase-3-like 1 proteinmultiple sclerosis

Substanzen

Chitinase-3-Like Protein 1BiomarkersCHI3L1 protein, human

Autor:innen und Institutionen

  • Department of Neurology, Medical University of Lodz, Kosciuszki Street 4, 90-419 Lodz, Poland.

ORCID-Profile: Izabela Jatczak-Pawlik, Małgorzata Domowicz, Alicja Ewiak-Paszyńska, Mariusz Stasiołek

Zitieren

APA

Jatczak-Pawlik, I., Jurewicz, A., Domowicz, M., Ewiak-Paszyńska, A., & Stasiołek, M. (2024). CHI3L1 in Multiple Sclerosis—From Bench to Clinic. Cells. https://doi.org/10.3390/cells13242086

Vancouver

Jatczak-Pawlik I, Jurewicz A, Domowicz M, Ewiak-Paszyńska A, Stasiołek M. CHI3L1 in Multiple Sclerosis—From Bench to Clinic. Cells. 2024. doi:10.3390/cells13242086

BibTeX
@article{JatczakPawlik2024,
  author = {Jatczak-Pawlik, Izabela and Jurewicz, Anna and Domowicz, Małgorzata and Ewiak-Paszyńska, Alicja and Stasiołek, Mariusz},
  title = {CHI3L1 in Multiple Sclerosis—From Bench to Clinic},
  journal = {Cells},
  year = {2024},
  doi = {10.3390/cells13242086}
}
Kostenlos starten →